Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer

<p>We sought information worldwide on mortality according to assigned treatment in all randomized trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early breast cancer (with or without regional lymph-node involvement). Coverage was reasonably complete for most countr...

書誌詳細
第一著者:	Early Breast Cancer Trialists' Collaborative Group
その他の著者:	Henderson, I
フォーマット:	Journal article
言語:	English
出版事項:	Massachusetts Medical Society 1988

類似資料

Tamoxifen for early breast cancer: an overview of the randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group
出版事項: (1998)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2011)

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
著者:: Early Breast Cancer Trialists’ Collaborative Group
出版事項: (2017)

Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials
著者:: Early Breast Cancer Trialists' Collaborative Group
出版事項: (1995)

Polychemotherapy for early breast cancer: an overview of the randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group
出版事項: (1998)

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2005)

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2008)

Ovarian ablation in early breast cancer: overview of the randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group
出版事項: (1996)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2022)

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2005)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2014)

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
著者:: Early Breast Cancer Trialists’ Collaborative group (EBCTCG)
出版事項: (2021)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
著者:: Early Breast Cancer Trialist's Collaborative Group
出版事項: (1992)

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2011)

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
著者:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
出版事項: (2011)

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
著者:: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
出版事項: (2010)

EFFECTS OF ADJUVANT TAMOXIFEN AND OF CYTOTOXIC THERAPY ON MORTALITY IN EARLY BREAST-CANCER - AN OVERVIEW OF 61 RANDOMIZED TRIALS AMONG 28,896 WOMEN
著者:: Peto, R
出版事項: (1989)

[Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer]
著者:: Davies, C, 等
出版事項: (1998)

WITHDRAWN: Tamoxifen for early breast cancer.
著者:: Clarke, M
出版事項: (2008)

Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells
著者:: Mohamed Alitheen, Noorjahan Banu, 等
出版事項: (2015)

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
著者:: Gelber, R, 等
出版事項: (1996)

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
著者:: Pan, H, 等
出版事項: (2017)

Tamoxifen in breast conservation therapy.
著者:: Lee, K, 等
出版事項: (1995)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
著者:: Davies, C, 等
出版事項: (2013)

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
著者:: Dowsett, M, 等
出版事項: (2009)

Variation in use of adjuvant tamoxifen.
著者:: Davies, C, 等
出版事項: (1998)

Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy
著者:: Lim, I-Liang, 等
出版事項: (2018)

Tamoxifen for early breast cancer: better late than never.
著者:: Gray, R, 等
出版事項: (2000)

Early breast cancer: How long should tamoxifen continue?
著者:: Davies, C, 等
出版事項: (1999)

Early breast cancer: How long should tamoxifen continue?
著者:: Davies, C, 等
出版事項: (1998)

THE EBCTCG OVERVIEW OF ADJUVANT THERAPY OF BREAST-CANCER
著者:: Gray, R, 等
出版事項: (1994)

Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview.
著者:: Clarke, M
出版事項: (2006)

Which adjuvant endocrine therapy for ER-positive non-metastatic breast cancer? EBCTCG-2000 update: Tamoxifen, castration, LHRH-agonists
著者:: Davies, C, 等
出版事項: (2002)

Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
著者:: Abdul Rafar, Noor Razilah, 等
出版事項: (2019)

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
著者:: Kerr, AJ, 等
出版事項: (2022)

The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study
著者:: O'Connell, R, 等
出版事項: (2019)

The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
著者:: Gray, R, 等
出版事項: (1993)

The benefits and harms of breast cancer screening: an independent review.
著者:: Independent UK Panel on Breast Cancer Screening
出版事項: (2012)

Adjuvant treatment for breast cancer
著者:: Flatley, M, 等
出版事項: (2019)

Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen.
著者:: Davies, C
出版事項: (2004)